Schedule 13D ownership disclosure

BIOSTAR PHARMACEUTICALS INC

Security class unavailable · CUSIP: 090678301

Event date: 2018-06-04

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
426,999
Percent of class
16.2000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001185185-18-001206
Form type
SC 13D
Filer
Biostar Pharmaceuticals, Inc.
CIK
CIK 1418133
Filed
Jul 02, 2018
Reporting period
Jun 04, 2018
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub